ESSA Pharma Inc

(NASDAQ:EPIX)

Latest On ESSA Pharma Inc (EPIX):

Date/Time Type Description Signal Details
2023-05-09 12:38 ESTNewsESSA Pharma GAAP EPS of -$0.16 beats by $0.04N/A
2023-02-07 18:44 ESTNewsESSA Pharma GAAP EPS of -$0.15N/A
2023-02-06 17:19 ESTNewsESSA Pharma: One Asset, One Program Company With Little DataN/A
2022-12-13 22:56 ESTNewsESSA Pharma GAAP EPS of -$0.14N/A
2022-11-16 11:07 ESTNewsESSA Pharma: EPI-7386+Xtandi Combination Has Shown Highest Efficacy In Metastatic, Castration-Resistant Prostate CancerN/A
2022-10-31 17:28 ESTNewsESSA drops 26% as Johnson & Johnson ends trial enrollment for lead assetN/A
2022-10-26 16:20 ESTNewsESSA Pharma jumps 91% on Phase 1/2 data for prostate cancer therapyN/A
2022-08-26 04:03 ESTNewsESSA Pharma Inc.: Selling For Under Cash ValueN/A
2022-08-04 10:30 ESTNewsESSA Pharma GAAP EPS of -$0.20N/A
2022-05-11 03:06 ESTNewsESSA Pharma GAAP EPS of -$0.25N/A
2022-04-14 22:07 ESTNewsESSA Pharma (EPIX) Presents At Oppenheimer Healthcare ConferenceN/A
2022-02-03 10:47 ESTNewsESSA Pharma GAAP EPS of -$0.21N/A
2022-01-19 11:50 ESTNewsESSA Pharma begins dosing of EPI-7386 in phase 1/2 prostate cancer studyN/A
2021-11-18 14:13 ESTNewsESSA Pharma EPS beats by $0.03N/A
2021-11-11 05:15 ESTNewsESSA Pharma: Why I Remain BullishN/A
2021-10-15 13:45 ESTNewsWarning: EPIX is at high risk of performing badlyN/A
2021-10-08 06:58 ESTNewsESSA Pharma rises ~5% amid preclinical data show for potential prostate cancer drugN/A
2021-10-07 09:41 ESTNewsEPIX is at high risk of performing badlyN/A
2021-10-07 09:31 ESTNewsESSA Pharma collaborates with Caris Life Sciences for liquid biopsy profilingN/A
2021-09-27 16:55 ESTNewsWarning: EPIX has been downgraded to Very BearishN/A
2021-09-23 02:07 ESTNewsWarning: EPIX has been downgraded to Very Bearish.N/A
2021-08-16 17:08 ESTNewsESSA Pharma reports Q3 resultsN/A
2021-08-16 17:08 ESTNewsESSA Pharma at an eight-month low after delaying data read from prostate cancer trialN/A
2021-08-10 03:13 ESTNewsESSA Pharma falls to six-month low on above average volumeN/A
2021-05-06 11:05 ESTNewsESSA Pharma reports Q1 resultsN/A
2021-03-14 14:00 ESTNewsESSA Pharma (ESSA) Investor Presentation - SlideshowN/A
2021-02-18 14:04 ESTNewsESSA Pharma prices equity offering at $27N/A
2021-02-17 02:49 ESTNewsESSA Pharma commences public offering of $100M sharesN/A
2021-02-12 23:41 ESTFinancialsCompany financials have been released.Neutral
2021-02-12 00:22 ESTNewsESSA Pharma reports Q4 resultsN/A
2021-02-12 00:21 ESTNewsESSA is up after early data for EPI-7386 in prostate cancerN/A
2021-02-02 07:08 ESTNewsESSA Pharma: Update Including Clinical Collaboration Agreement With JanssenN/A
2021-01-13 13:03 ESTNewsESSA Pharma and Janssen to test combo treatments in prostate cancer settingN/A
2020-12-17 03:42 ESTFinancialsCompany financials have been released.Neutral
2020-12-16 05:14 ESTNewsESSA Pharma EPS beats by $0.02N/A
2020-11-26 19:53 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:44 ESTFinancialsCompany financials have been released.Neutral
2020-10-31 14:56 ESTNewsESSA Pharma to delist from from TSX-VN/A
2020-09-26 12:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:47 ESTFinancialsCompany financials have been released.Neutral
2020-09-14 08:55 ESTNewsESSA Pharma nabs U.S. accelerated review tag for prostate cancer drugN/A
2020-09-01 00:38 ESTFinancialsCompany financials have been released.Neutral
2020-08-20 16:43 ESTNewsESSA's Novel Prostate Cancer Treatment In Clinical Trial: Pfizer Is New Lead InvestorN/A
2020-08-14 08:42 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 00:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 17:32 ESTNewsESSA Pharma EPS beats by $0.06N/A
2020-07-31 21:38 ESTNewsESSA Pharma completes $49M aggregate gross proceedsN/A
2020-07-31 00:54 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 19:32 ESTNewsESSA Pharma prices equity offering at $6/shareN/A
2020-07-28 20:30 ESTNewsESSA pharma launches equity offeringN/A

About ESSA Pharma Inc (EPIX):

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

EPIX Quotes by TradingView

See Advanced Chart

General

  • Name ESSA Pharma Inc
  • Symbol EPIX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 25
  • Last Split Factor1:20
  • Last Split Date2018-04-25
  • Fiscal Year EndSeptember
  • IPO Date2015-07-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.essapharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 16.91
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Return on Assets -26%
  • Return on Equity -42%
  • Earnings Per Share -$1.75
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.2 billion
  • EBITDA -11033670
  • Analyst Target Price $0.75
  • Book Value Per Share $2.21
View More

Share Statistics

  • Shares Outstanding 39.34 million
  • Shares Float 20.9 million
  • % Held by Insiders 281%
  • % Held by Institutions 64.04%
  • Shares Short 62217
  • Shares Short Prior Month 62714
  • Short Ratio 0.11
View More

Technicals

  • Beta 1.78
  • 52 Week High $32.65
  • 52 Week Low $3.5
  • 50 Day Moving Average 25.25
  • 200 Day Moving Average 12.6
View More

Dividends

  • Dividend Date 2018-04-25
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ESSA Pharma Inc (EPIX) Dividend Calendar:

EPIX's last dividend payment was made to shareholders on April 25, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ESSA Pharma Inc (EPIX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-11$N/A-$0.20-$0.17-20.8%
2020-09-302020-12-15$N/A-$0.17-$0.2015.3%
2020-06-302020-08-06$N/A-$0.24-$0.3633.44%
2020-03-312020-05-07$N/A-$0.45-$0.22-105.2%
2019-12-312020-02-13$N/A-$0.22-$0.18-22.63%
2019-09-302019-12-19$N/A-$0.23-$0.17-32.13%
2019-06-302019-08-14$N/A-$0.52-$0.544.29%
2019-03-312019-05-10$N/A-$0.54-$0.44-23.36%
2018-12-312019-02-07$N/A-$0.43
2018-09-302018-12-13$N/A-$0.40-$0.437.29%
2018-06-302018-08-14$N/A-$0.50-$0.7432.34%
2018-03-312018-05-14$N/A-$0.83-$0.40-104.75%
2017-12-312018-02-13$N/A-$1.40
2017-09-302017-12-12$N/A-$1.40-$3.6461.53%
2017-06-302017-08-15$N/A-$3.16-$3.5310.35%
2017-03-312017-05-15$N/A-$5.21-$2.20-136.74%
2016-12-312017-02-13$N/A$0.92
2016-09-302016-12-14$N/A-$3.15
2016-06-302016-08-12$N/A-$2.66
2016-03-312016-05-13$N/A-$0.78
2015-12-312016-02-12$N/A-$2.30-$2.8118.09%
2015-09-302015-12-14$N/A$0.08-$0.07214.29%
2015-06-302015-08-17$N/A-$0.26-$0.13-100%
2015-03-312015-05-28$N/A-$0.20-$0.229.09%

ESSA Pharma Inc (EPIX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ESSA Pharma Inc (EPIX) Chart:

EPIX chart by TradingView

ESSA Pharma Inc (EPIX) News:

Below you will find a list of latest news for ESSA Pharma Inc (EPIX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ESSA Pharma Inc (EPIX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.53.6CALL0 10744.6TRUE00
2024-05-1750CALL0 0457.82TRUE00
2024-05-177.50.35CALL1 23102.8FALSE0.350
2024-05-17100.15CALL0 200FALSE00
2024-05-1712.50.05CALL0 70FALSE00
2024-05-17150CALL0 00FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.51.5PUT0 330TRUE00
2024-05-17100PUT0 0330TRUE00
2024-05-1712.50PUT0 0419.48TRUE00
2024-05-17150PUT0 0484.89TRUE00
2024-05-1717.50PUT0 0509.1TRUE00
2024-06-212.50CALL0 0188.21TRUE00
2024-06-2150CALL0 0243TRUE00
2024-06-217.50CALL0 00FALSE00
2024-06-21100.2CALL0 110FALSE00
2024-06-2112.50CALL0 00FALSE00
2024-06-21150CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 0140.23TRUE00
2024-06-21100PUT0 0140.71TRUE00
2024-06-2112.50PUT0 0196.97TRUE00
2024-06-21150PUT0 0264.52TRUE00
2024-07-192.55.4CALL0 6270.47TRUE00
2024-07-1951.7CALL0 32101.88TRUE00
2024-07-197.51CALL5 7493.29FALSE10
2024-07-19100.2CALL0 400FALSE00
2024-07-1912.51.46CALL0 1570FALSE00
2024-07-19150.7CALL0 42137.73FALSE00
2024-07-1917.50.4CALL0 150FALSE00
2024-07-192.50.35PUT0 20FALSE00
2024-07-1950.78PUT0 1126.36FALSE00
2024-07-197.52.08PUT0 14113.18TRUE00
2024-07-19103.19PUT0 0143.42TRUE00
2024-07-1912.55.15PUT0 6193.12TRUE00
2024-07-19157.5PUT0 11175.26TRUE00
2024-07-1917.50PUT0 0230.06TRUE00
2024-10-182.50CALL0 0128.45TRUE00
2024-10-1852.9CALL0 45188.28TRUE00
2024-10-187.51.97CALL0 18122.77FALSE00
2024-10-18101.35CALL0 180FALSE00
2024-10-1812.51CALL0 400FALSE00
2024-10-18151.86CALL0 2138.07FALSE00
2024-10-1817.51.54CALL0 46139.11FALSE00
2024-10-182.50PUT0 0157.52FALSE00
2024-10-1850PUT0 00FALSE00
2024-10-187.52.1PUT0 2124.9TRUE00
2024-10-18103.7PUT0 6133.45TRUE00
2024-10-1812.50PUT0 0127.79TRUE00
2024-10-18150PUT0 0137.18TRUE00
2024-10-1817.50PUT0 0182.38TRUE00

Latest EPIX Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST25$4.35
Jun 13, 2022 7:58 PM EST100$4.405
Jun 13, 2022 7:58 PM EST5$4.39
Jun 13, 2022 7:59 PM EST100$4.41
Jun 13, 2022 7:59 PM EST5$4.39

ESSA Pharma Inc (EPIX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633932/000110465920078083/0001104659-20-078083-index.htm
2018-01-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633932/000000000018003384/0000000000-18-003384-index.htm
2018-07-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633932/000000000018020699/0000000000-18-020699-index.htm
2019-10-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1633932/000000000019014646/0000000000-19-014646-index.htm
2020-08-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000007800320000062/0000078003-20-000062-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000089924320026708/0000899243-20-026708-index.htm
2018-10-17SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092189518002790/0000921895-18-002790-index.htm
2019-06-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092189519001918/0000921895-19-001918-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092189520000523/0000921895-20-000523-index.htm
2019-08-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092963819000785/0000929638-19-000785-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092963820000238/0000929638-20-000238-index.htm
2020-08-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000092963820000796/0000929638-20-000796-index.htm
2019-11-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000094787119000801/0000947871-19-000801-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000094787120000697/0000947871-20-000697-index.htm
2019-08-30DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000095017219000105/0000950172-19-000105-index.htm
2019-11-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633932/000110465919058826/0001104659-19-058826-index.htm
2019-11-05F-3/ARegistration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1633932/000110465919059949/0001104659-19-059949-index.htm
2019-12-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633932/000110465919074530/0001104659-19-074530-index.htm
2020-04-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1633932/000110465920045976/0001104659-20-045976-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000110465920046029/0001104659-20-046029-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000110465920046990/0001104659-20-046990-index.htm
2020-06-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633932/000110465920078083/0001104659-20-078083-index.htm
2020-07-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1633932/000110465920087327/0001104659-20-087327-index.htm
2020-07-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1633932/000110465920088000/0001104659-20-088000-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000110465920091290/0001104659-20-091290-index.htm
2020-08-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633932/000110465920094164/0001104659-20-094164-index.htm
2019-10-09F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1633932/000114420419047713/0001144204-19-047713-index.htm
2018-01-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633932/000119312518027466/0001193125-18-027466-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000119312518037709/0001193125-18-037709-index.htm
2018-05-18S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1633932/000119312518168189/0001193125-18-168189-index.htm
2018-05-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1633932/000119312518168196/0001193125-18-168196-index.htm
2018-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000119312518196616/0001193125-18-196616-index.htm
2019-01-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000119312519006217/0001193125-19-006217-index.htm
2019-02-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000119312519037826/0001193125-19-037826-index.htm
2019-09-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000119312519240118/0001193125-19-240118-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000119312520037345/0001193125-20-037345-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000119380518000213/0001193805-18-000213-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052722/0001209191-20-052722-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052723/0001209191-20-052723-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052724/0001209191-20-052724-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052725/0001209191-20-052725-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052726/0001209191-20-052726-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052727/0001209191-20-052727-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052729/0001209191-20-052729-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052730/0001209191-20-052730-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052748/0001209191-20-052748-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120052750/0001209191-20-052750-index.htm
2020-10-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120053375/0001209191-20-053375-index.htm
2020-10-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1633932/000120919120053376/0001209191-20-053376-index.htm
2020-11-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000121390020035602/0001213900-20-035602-index.htm
2018-02-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000243/0001279569-18-000243-index.htm
2018-02-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000321/0001279569-18-000321-index.htm
2018-03-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000386/0001279569-18-000386-index.htm
2018-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000602/0001279569-18-000602-index.htm
2018-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000783/0001279569-18-000783-index.htm
2018-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000796/0001279569-18-000796-index.htm
2018-04-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000806/0001279569-18-000806-index.htm
2018-04-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000819/0001279569-18-000819-index.htm
2018-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918000962/0001279569-18-000962-index.htm
2018-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918001032/0001279569-18-001032-index.htm
2018-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918001059/0001279569-18-001059-index.htm
2018-05-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918001166/0001279569-18-001166-index.htm
2018-06-28F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1633932/000127956918001382/0001279569-18-001382-index.htm
2018-07-12F-3/ARegistration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1633932/000127956918001468/0001279569-18-001468-index.htm
2018-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1633932/000127956918001470/0001279569-18-001470-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918001704/0001279569-18-001704-index.htm
2018-08-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918001774/0001279569-18-001774-index.htm
2018-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918002070/0001279569-18-002070-index.htm
2018-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918002207/0001279569-18-002207-index.htm
2018-12-1320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1633932/000127956918002468/0001279569-18-002468-index.htm
2018-12-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956918002470/0001279569-18-002470-index.htm
2019-02-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000240/0001279569-19-000240-index.htm
2019-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000258/0001279569-19-000258-index.htm
2019-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000337/0001279569-19-000337-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000578/0001279569-19-000578-index.htm
2019-03-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000610/0001279569-19-000610-index.htm
2019-03-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000750/0001279569-19-000750-index.htm
2019-03-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000751/0001279569-19-000751-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000885/0001279569-19-000885-index.htm
2019-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000925/0001279569-19-000925-index.htm
2019-04-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919000970/0001279569-19-000970-index.htm
2019-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001052/0001279569-19-001052-index.htm
2019-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001142/0001279569-19-001142-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001201/0001279569-19-001201-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001264/0001279569-19-001264-index.htm
2019-06-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001415/0001279569-19-001415-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001434/0001279569-19-001434-index.htm
2019-06-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001441/0001279569-19-001441-index.htm
2019-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001488/0001279569-19-001488-index.htm
2019-07-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001524/0001279569-19-001524-index.htm
2019-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001607/0001279569-19-001607-index.htm
2019-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001617/0001279569-19-001617-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001769/0001279569-19-001769-index.htm
2019-08-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001822/0001279569-19-001822-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001838/0001279569-19-001838-index.htm
2019-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001871/0001279569-19-001871-index.htm
2019-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919001956/0001279569-19-001956-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002001/0001279569-19-002001-index.htm
2019-10-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002063/0001279569-19-002063-index.htm
2019-10-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002139/0001279569-19-002139-index.htm
2019-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002147/0001279569-19-002147-index.htm
2019-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002177/0001279569-19-002177-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002192/0001279569-19-002192-index.htm
2019-12-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956919002524/0001279569-19-002524-index.htm
2020-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000155/0001279569-20-000155-index.htm
2020-02-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000172/0001279569-20-000172-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000227/0001279569-20-000227-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000448/0001279569-20-000448-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000514/0001279569-20-000514-index.htm
2020-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000642/0001279569-20-000642-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000703/0001279569-20-000703-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000787/0001279569-20-000787-index.htm
2020-05-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000840/0001279569-20-000840-index.htm
2020-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920000962/0001279569-20-000962-index.htm
2020-07-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001061/0001279569-20-001061-index.htm
2020-07-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001105/0001279569-20-001105-index.htm
2020-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001109/0001279569-20-001109-index.htm
2020-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001131/0001279569-20-001131-index.htm
2020-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001172/0001279569-20-001172-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001290/0001279569-20-001290-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001299/0001279569-20-001299-index.htm
2020-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001330/0001279569-20-001330-index.htm
2020-09-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1633932/000127956920001340/0001279569-20-001340-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000153526418000014/0001535264-18-000014-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1633932/000156459020047744/0001564590-20-047744-index.htm
2018-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000158064218000855/0001580642-18-000855-index.htm
2018-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000158064218001488/0001580642-18-001488-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000158064219000774/0001580642-19-000774-index.htm
2019-05-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000158064219002593/0001580642-19-002593-index.htm
2019-07-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1633932/000158064219003213/0001580642-19-003213-index.htm
2019-08-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000158064219004061/0001580642-19-004061-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1633932/000158064220000511/0001580642-20-000511-index.htm
2018-02-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633932/999999999518000329/9999999995-18-000329-index.htm
2018-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633932/999999999518001814/9999999995-18-001814-index.htm
2019-11-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1633932/999999999519002482/9999999995-19-002482-index.htm